why choose us

First received: March 01, 2023

Clinical Trial: Fecal Microbiota Transplantation for IBS

Study Status: Completed

Recruit Status: RECRUITING

Condition: Irritable Bowel Syndrome

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)

Brief Summary: The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with post-infection irritable bowel syndrome (PI-IBS) and high proteolytic activity.Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids.

Read more